![NOVAVAX INC [NVAX] reports annual net loss of $545,062,000.0](/_next/image?url=https%3A%2F%2F10kinfo-appdata.s3.us-west-2.amazonaws.com%2Fedgar0105%2FCompanyLogos%2FUS%2FNVAX.png&w=3840&q=75)
NOVAVAX INC [NVAX] reports annual net loss of $545,062,000.0
Company Reports Revenue of $983.7 million
NOVAVAX INC [NVAX] has reported a net loss of $545,062,000.0 for year ended Dec 31, 2023.
The Company said in a filing before the Securities and Exchange Commission that its total revenue for the year was $983.7 million
Based in GAITHERSBURG, Maryland, NOVAVAX INC operates in the MANUFACTURING sector.
In the 12 months that ended on December 31, 2023, the consolidated revenue totaled $983.7 million. This reflects a decrease from the previous year's revenue of $1,981.9 million. In comparison to the revenue reported in December 31, 2021, which amounted to $1,146.3 million, the current year's revenue also decreased.
Moving on to expenses, the cost of sales for the current period stood at $343.8 million. This represents a decrease from the previous year's cost of sales, which amounted to $902.6 million. Notably, there were no reported cost of sales for the period ending December 31, 2021.
